Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) Posts Quarterly Earnings Results

by · The Cerbat Gem

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported $0.91 earnings per share (EPS) for the quarter, Zacks reports. Recordati Industria Chimica E Farmaceutica had a net margin of 17.81% and a return on equity of 34.38%.

Recordati Industria Chimica E Farmaceutica Price Performance

Shares of OTCMKTS RCDTF opened at $58.00 on Thursday. The firm has a market cap of $11.97 billion, a PE ratio of 21.94 and a beta of 0.25. The company has a current ratio of 1.26, a quick ratio of 0.86 and a debt-to-equity ratio of 0.85. Recordati Industria Chimica E Farmaceutica has a 1-year low of $55.88 and a 1-year high of $60.00. The company has a fifty day moving average price of $58.67 and a 200 day moving average price of $59.41.

About Recordati Industria Chimica E Farmaceutica

(Get Free Report)

Recordati Industria Chimica e Farmaceutica is an Italy‐based international pharmaceutical company engaged in the research, development, manufacturing and commercialization of therapeutic products. Established in 1926, the company has built a diversified portfolio that includes proprietary drugs, generics and orphan medicines, with a particular emphasis on treatments for rare diseases. Recordati’s product range spans cardiovascular, urology, endocrinology, dermatology and oncology therapies, as well as specialized formulations for genetic and metabolic disorders.

The company’s historical roots date back nearly a century, when it began as a family‐owned enterprise in Milan.

Recommended Stories